Bank CEOs meet with Trump to discuss Fannie Mae and Freddie Mac - Bloomberg
SEATTLE—Fawwad Qureshi, Chief Financial Officer of Trupanion, Inc. (NASDAQ:TRUP), recently sold 2,416 shares of the company’s common stock. The shares were sold at a weighted average price of $33.88, resulting in a total transaction value of $81,863. This sale was conducted as part of a pre-established trading plan designed for financial diversification. The transaction comes as Trupanion’s stock has experienced a 28% decline over the past six months, with current trading showing an RSI in oversold territory, according to InvestingPro data.
In addition to the sale, Mr. Qureshi was granted 41,980 restricted stock units (RSUs) on February 27, 2025. These RSUs will convert into common stock in stages, with the first vesting scheduled for May 25, 2025, and subsequent vesting occurring quarterly, contingent upon continued service with the company. While currently showing a Fair Value upside according to InvestingPro analysis, the company maintains strong liquidity with a current ratio of 1.69 and analysts project a return to profitability this year.
The transactions reflect ongoing strategic financial planning by Trupanion’s executive team, aligning with industry practices for managing equity compensation and personal financial objectives. For deeper insights into Trupanion’s financial health and detailed analysis, access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks.
In other recent news, Trupanion Inc . reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) with a reported $0.04 against the forecasted $0.07. However, the company’s revenue slightly exceeded expectations, reaching $337.3 million compared to the anticipated $335.46 million. Trupanion’s subscription revenue saw a 19% year-over-year growth, contributing to the overall revenue increase of 14%. Despite these positive financial indicators, the company faced challenges with subscriber growth, which showed a 10% decline year-over-year in new subscribers.
The company also experienced a slowdown in revenue growth due to recent rate increases, as indicated in its 2025 guidance. Analysts from Stifel and Piper Sandler both revised their price targets for Trupanion, with Stifel lowering it to $41 from $44 and Piper Sandler reducing it to $52 from $57. Stifel maintained a Hold rating, while Piper Sandler kept an Overweight rating on the shares. Analysts expressed concerns over Trupanion’s retention rates and subscriber growth, although the company did achieve a 70% loss ratio and a 15.3% adjusted operating margin in its subscription business.
Additionally, Trupanion wrote off approximately $5.3 million in goodwill related to acquisitions in Europe, specifically Smart Paws and PetExpert. As the company navigates these developments, its future performance continues to be closely monitored by investors and analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.